Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding ‘efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis’ (Dutta et al.)

Response to the letter to the editor submitted by Jaiswal A et al. (2020) regarding ‘efficacy and safety of saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis’ (Dutta et al.)

Saved in:
Bibliographic Details
Published in:Diabetes & metabolic syndrome clinical research & reviews Vol. 14; no. 6; p. 2093
Main Authors: D, Dutta, S, Bhattacharya, V, Surana, S, Aggarwal, R, Singla, D, Khandelwal, M, Sharma
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-11-2020
Subjects:
Cardiovascular Diseases
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Double-Blind Method
Glycemic Control
Humans
Hypertriglyceridemia - drug therapy
Lipids
Phenylpropionates
Pyrroles
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1871-4021
1878-0334
DOI:10.1016/j.dsx.2020.10.027